Resultats de la cerca - Giuseppe Schepisi
- Mostrar 1 - 9 resultats de 9
-
1
-
2
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer per Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli, Ugo De Giorgi
Publicat 2023Revisão -
3
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide per Marzia Del Re, Vincenza Conteduca, Stefania Crucitta, Giorgia Gurioli, Chiara Casadei, Giuliana Restante, Giuseppe Schepisi, Cristian Lolli, Federico Cucchiara, Romano Danesi, Ugo De Giorgi
Publicat 2021Artigo -
4
CAR-T cell therapy: a potential new strategy against prostate cancer per Giuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, Cecilia Menna, Amelia Altavilla, Cristian Lolli, Claudio Cerchione, Giovanni Paganelli, Daniele Santini, Giuseppe Tonini, Giovanni Martinelli, Ugo De Giorgi
Publicat 2019Revisão -
5
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment per Caterina Gianni, Michela Palleschi, Giuseppe Schepisi, Chiara Casadei, Sara Bleve, Filippo Merloni, Marianna Sirico, Samanta Sarti, Lorenzo Cecconetto, Giandomenico Di Menna, Francesco Schettini, Ugo De Giorgi
Publicat 2022Revisão -
6
Circulating <i>AR</i> copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer per Samanta Salvi, Valentina Casadio, Vincenza Conteduca, Cristian Lolli, Giorgia Gurioli, Filippo Martignano, Giuseppe Schepisi, Sara Testoni, Emanuela Scarpi, Dino Amadori, Daniele Calistri, Gerhardt Attard, Ugo De Giorgi
Publicat 2016Artigo -
7
Immunotherapy for Prostate Cancer: Where We Are Headed per Giuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, Filippo Martignano, Delia De Lisi, Giorgia Ravaglia, Lorena Rossi, Cecilia Menna, S.R. Bellia, Domenico Barone, Roberta Gunelli, Ugo De Giorgi
Publicat 2017Revisão -
8
Psychosocial Issues in Long-Term Survivors of Testicular Cancer per Giuseppe Schepisi, Silvia De Padova, Delia De Lisi, Chiara Casadei, Elena Meggiolaro, Federica Ruffilli, Giovanni Rosti, Cristian Lolli, Giorgia Ravaglia, Vincenza Conteduca, Alberto Farolfi, Luigi Grassi, Ugo De Giorgi
Publicat 2019Revisão -
9
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer per Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, Daniel Wetterskog, Samanta Salvi, Giorgia Gurioli, Emanuela Scarpi, Elena Castro, Mercedes Marín‐Aguilera, Cristian Lolli, Giuseppe Schepisi, Antonio Maugeri, Anna Wingate, Alberto Farolfi, Valentina Casadio, Ana Medina, Javier Puente, Ma José Méndez Vidal, Rafael Morales-Bárrera, José Carlos Villa-Guzmán, Susana Hernando, Alejo Rodríguez‐Vida, Aránzazu González del Alba, Begoña Mellado, Enrique González‐Billalabeitia, David Olmos, Gerhardt Attard, Ugo De Giorgi
Publicat 2018Carta
Eines de cerca:
Matèries relacionades
Cancer
Internal medicine
Medicine
Oncology
Immunotherapy
Prostate cancer
Biology
Cancer research
Androgen receptor
Breast cancer
Enzalutamide
Immune system
Immunology
Androgen deprivation therapy
Antigen
Cabazitaxel
Cancer immunotherapy
Cell
Cell therapy
Chemotherapy
Chimeric antigen receptor
Disease
Docetaxel
Genetics
T cell
Urology
Abiraterone
Abiraterone acetate
Affect (linguistics)
Androgen